Drug Shortage Report for TEVA-MYCOPHENOLATE
| Report ID | 107949 |
| Drug Identification Number | 02364883 |
| Brand name | TEVA-MYCOPHENOLATE |
| Common or Proper name | MYCOPHENOLATE 250MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
| Strength(s) | 250MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | U/D 100's |
| ATC code | L04AA |
| ATC description | IMMUNOSUPPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-03-18 |
| Estimated end date | 2020-06-30 |
| Actual end date | 2020-06-30 |
| Shortage status | Resolved |
| Updated date | 2020-07-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-03-06 | English | Compare |